TGFB1 and neoplasm: Combined PD-L1/TGF-β blockade in immune-excluded tumour models permits expansion and differentiation of stem cell-like CD8+ T cells, replacing dysfunctional-exhausted T cell pools and generating IFNghi effector cells that remodel myeloid and stromal niches into an immune-supportive TME [188].